{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:24:00Z","timestamp":1784751840509,"version":"3.55.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.trsl.2026.06.017","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:24:28Z","timestamp":1782314668000},"page":"120-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SynNotch-iNOS CAR-macrophages remodel the tumor immune microenvironment and exhibit antitumor efficacy via a CD4+ T cell-dependent mechanism"],"prefix":"10.1016","volume":"295","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6648-2645","authenticated-orcid":false,"given":"Yuling","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buyun","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cixin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3699-6009","authenticated-orcid":false,"given":"Qingxiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1251-8774","authenticated-orcid":false,"given":"Shih-Chin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2026.06.017_bib0001","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","article-title":"Macrophages, innate immunity and cancer: balance, tolerance, and diversity","volume":"22","author":"Mantovani","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0002","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2026.06.017_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112253","article-title":"Heterogeneity of myeloid cells in common cancers: single cell insights and targeting strategies","volume":"134","author":"Jing","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0004","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2353\/ajpath.2009.080676","article-title":"High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors","volume":"174","author":"Ojalvo","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cellimm.2018.02.008","article-title":"Myeloid cell heterogeneity in cancer: not a single cell alike","volume":"330","author":"Kiss","year":"2018","journal-title":"Cell Immunol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13045-023-01473-x","article-title":"Tumor-associated myeloid cells in cancer immunotherapy","volume":"16","author":"Cheng","year":"2023","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0007","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/s41551-023-01031-3","article-title":"Cooperative phagocytosis of solid tumours by macrophages triggers durable anti-tumour responses","volume":"7","author":"Dooling","year":"2023","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.trsl.2026.06.017_bib0008","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1073\/pnas.1121623109","article-title":"The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors","volume":"109","author":"Willingham","year":"2012","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2026.06.017_bib0009","first-page":"85","article-title":"CD169-Positive macrophages dominate antitumor immunity by","volume":"34","author":"Asano","year":"2011","journal-title":"Crosspresenting Dead Cell-Associated Antigens. Immunity."},{"key":"10.1016\/j.trsl.2026.06.017_bib0010","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.155022","article-title":"CD206+tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity","volume":"7","author":"Modak","year":"2022","journal-title":"Jci Insight"},{"key":"10.1016\/j.trsl.2026.06.017_bib0011","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.coi.2017.12.001","article-title":"Developmental control of macrophage function","volume":"50","author":"Bonnardel","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0012","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/febs.14288","article-title":"Tumor-associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy","volume":"285","author":"Porta","year":"2018","journal-title":"Febs J"},{"key":"10.1016\/j.trsl.2026.06.017_bib0013","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13045-020-00983-2","article-title":"Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions","volume":"13","author":"Zhang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0014","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00262-024-03759-6","article-title":"Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers","volume":"73","author":"Chupradit","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.trsl.2026.06.017_bib0015","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0016","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","article-title":"A second-generation M1-polarized CAR macrophage with antitumor efficacy","volume":"25","author":"Lei","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0017","doi-asserted-by":"crossref","first-page":"465","DOI":"10.17305\/bb.2023.9675","article-title":"CAR-macrophage versus CAR-T for solid tumors: the race between a rising star and a superstar","volume":"24","author":"Chen","year":"2024","journal-title":"Biomol Biomed"},{"key":"10.1016\/j.trsl.2026.06.017_bib0018","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13046-022-02327-z","article-title":"CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy","volume":"41","author":"Pan","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.trsl.2026.06.017_bib0019","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1038\/s41467-023-41470-9","article-title":"Metabolic reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2026.06.017_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41590-023-01696-7","article-title":"CAR macrophages on a fast track to solid tumor therapy","volume":"25","author":"Abdin","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103873","article-title":"CAR-macrophage: an extensive immune enhancer to fight cancer","volume":"76","author":"Wang","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.trsl.2026.06.017_bib0022","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2016.01.012","article-title":"Engineering customized cell sensing and response behaviors using synthetic notch receptors","volume":"164","author":"Morsut","year":"2016","journal-title":"Cell."},{"key":"10.1016\/j.trsl.2026.06.017_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1545270","article-title":"SynNotch CAR-T cell, when synthetic biology and immunology meet again","volume":"16","author":"Shirzadian","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0024","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.niox.2008.04.023","article-title":"Nitric oxide\u2013a novel therapeutic for cancer","volume":"19","author":"Coulter","year":"2008","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.trsl.2026.06.017_bib0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/med.20092","article-title":"Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities","volume":"27","author":"Mocellin","year":"2007","journal-title":"Med Res Rev"},{"key":"10.1016\/j.trsl.2026.06.017_bib0026","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s00268-002-4051-7","article-title":"Inducible nitric oxide synthase: from cloning to therapeutic applications","volume":"26","author":"Schwentker","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.trsl.2026.06.017_bib0027","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj3570593","article-title":"Nitric oxide synthases: structure, function and inhibition","volume":"357","author":"Alderton","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.trsl.2026.06.017_bib0028","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.lfs.2003.10.042","article-title":"iNOS-mediated nitric oxide production and its regulation","volume":"75","author":"Aktan","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.trsl.2026.06.017_bib0029","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrc1910","article-title":"The role of nitric oxide in tumour progression","volume":"6","author":"Fukumura","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2026.06.017_bib0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.freeradbiomed.2008.03.020","article-title":"The chemical biology of nitric oxide: implications in cellular signaling","volume":"45","author":"Thomas","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.trsl.2026.06.017_bib0031","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.niox.2008.05.003","article-title":"The reemergence of nitric oxide and cancer","volume":"19","author":"Wink","year":"2008","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.trsl.2026.06.017_bib0032","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1021\/acs.jmedchem.6b01075","article-title":"Potent inhibition of nitric oxide-releasing bifendate derivatives against drug-resistant K562\/A02 cells in vitro and in vivo","volume":"60","author":"Gu","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.trsl.2026.06.017_bib0033","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bbrc.2014.04.032","article-title":"Novel nitric oxide generating compound glycidyl nitrate enhances the therapeutic efficacy of chemotherapy and radiotherapy","volume":"447","author":"Ning","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2026.06.017_bib0034","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.niox.2008.04.018","article-title":"Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases","volume":"19","author":"Bonavida","year":"2008","journal-title":"Nitric Oxide-Biol Ch"},{"key":"10.1016\/j.trsl.2026.06.017_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2010.10.001","article-title":"Dual role of NO donors in the reversal of tumor cell resistance and EMT: downregulation of the NF-\u03bab\/snail\/YY1\/RKIP circuitry","volume":"24","author":"Bonavida","year":"2011","journal-title":"Nitric Oxide-Biol Ch"},{"key":"10.1016\/j.trsl.2026.06.017_bib0036","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/hep.510240124","article-title":"Role in nitric oxide in Kupffer cell-mediated hepatoma cell cytotoxicity in vitro and ex vivo","volume":"24","author":"Fukumura","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2026.06.017_bib0037","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3389\/fimmu.2018.01684","article-title":"Tumor killing by CD4(+) T cells is mediated via induction of inducible nitric oxide synthase-dependent macrophage cytotoxicity","volume":"9","author":"Fauskanger","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0038","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41586-023-06199-x","article-title":"CD4(+) T cell-induced inflammatory cell death controls immune-evasive tumours","volume":"618","author":"Kruse","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2026.06.017_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2024.04.011","article-title":"Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy","volume":"42","author":"van Elsas","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trsl.2026.06.017_bib0040","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/sj.gt.3301197","article-title":"A simple method for the rapid generation of recombinant adenovirus vectors","volume":"7","author":"Anderson","year":"2000","journal-title":"Gene Ther"},{"key":"10.1016\/j.trsl.2026.06.017_bib0041","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nprot.2007.135","article-title":"A protocol for rapid generation of recombinant adenoviruses using the AdEasy system","volume":"2","author":"Luo","year":"2007","journal-title":"Nat Protoc"},{"issue":"16","key":"10.1016\/j.trsl.2026.06.017_bib0042","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.3390\/cancers14163871","article-title":"Circulating cells with macrophage-like characteristics in cancer: the importance of Circulating neoplastic-immune hybrid cells in cancer","volume":"14","author":"Sutton","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trsl.2026.06.017_bib0043","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat7828","article-title":"Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival","volume":"4","author":"Gast","year":"2018","journal-title":"Sci Adv"},{"key":"10.1016\/j.trsl.2026.06.017_bib0044","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2026.06.017_bib0045","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.1158\/0008-5472.CAN-04-1449","article-title":"A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors","volume":"64","author":"Wyckoff","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2026.06.017_bib0046","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1158\/0008-5472.CAN-06-1823","article-title":"Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors","volume":"67","author":"Wyckoff","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2026.06.017_bib0047","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/15384101.2016.1241929","article-title":"Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer","volume":"16","author":"Zhang","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trsl.2026.06.017_bib0048","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41586-018-0590-4","article-title":"Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris","volume":"562","author":"Tabula Muris","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2026.06.017_bib0049","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ni.2419","article-title":"Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages","volume":"13","author":"Gautier","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0051","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","article-title":"T cell exhaustion","volume":"42","author":"Baessler","year":"2024","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0052","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1172\/JCI46102","article-title":"Exhaustion of tumor-specific CD8(+) T cells in metastases from melanoma patients","volume":"121","author":"Baitsch","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2026.06.017_bib0053","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.05.017","article-title":"Intratumoral CD4(+) T cells mediate anti-tumor cytotoxicity in Human bladder cancer","volume":"181","author":"Oh","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2026.06.017_bib0055","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20091918","article-title":"Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts","volume":"207","author":"Quezada","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2026.06.017_bib0056","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2217\/imt.11.83","article-title":"Tumor-reactive CD4+ T cells: plasticity beyond helper and regulatory activities","volume":"3","author":"Quezada","year":"2011","journal-title":"Immunotherapy"},{"issue":"2","key":"10.1016\/j.trsl.2026.06.017_bib0057","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142513","article-title":"PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells","volume":"6","author":"Balanca","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2026.06.017_bib0058","first-page":"4234","article-title":"CD4(+) T cell exhaustion leads to adoptive transfer therapy failure which can be prevented by immune checkpoint blockade","volume":"10","author":"Fu","year":"2020","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.trsl.2026.06.017_bib0059","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1158\/1078-0432.CCR-21-0206","article-title":"CD4 T-cell exhaustion: does it exist and what are its roles in cancer?","volume":"27","author":"Miggelbrink","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2026.06.017_bib0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/intimm\/dxw025","article-title":"Roles of regulatory T cells in cancer immunity","volume":"28","author":"Takeuchi","year":"2016","journal-title":"Int Immunol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0061","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","article-title":"Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trsl.2026.06.017_bib0062","article-title":"The role of Foxp3 and Tbet co-expressing treg cells in lung carcinoma","volume":"7","author":"Kachler","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.trsl.2026.06.017_bib0063","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40425-019-0497-0","article-title":"Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses","volume":"7","author":"Santegoets","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.trsl.2026.06.017_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112813","article-title":"A genetic method specifically delineates Th1-type treg cells and their roles in tumor immunity","volume":"42","author":"Okamoto","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.trsl.2026.06.017_bib0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2026.06.017_bib0066","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10555-006-9001-7","article-title":"Role of tumor-associated macrophages in tumor progression and invasion","volume":"25","author":"Mantovani","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.trsl.2026.06.017_bib0067","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2026.06.017_bib0068","doi-asserted-by":"crossref","DOI":"10.1126\/science.adn8608","article-title":"Platelet factor 4-induced T(H)1-T(reg) polarization suppresses antitumor immunity","volume":"386","author":"Kuratani","year":"2024","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.trsl.2026.06.017_bib0069","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221388","article-title":"Trained immunity of alveolar macrophages enhances injury resolution via KLF4-MERTK-mediated efferocytosis","volume":"220","author":"Chakraborty","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2026.06.017_bib0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1165\/rcmb.2017-0328ED","article-title":"Monocyte-derived alveolar macrophages: the dark side of lung repair?","volume":"58","author":"McQuattie-Pimentel","year":"2018","journal-title":"Am J Resp Cell Mol"},{"issue":"11","key":"10.1016\/j.trsl.2026.06.017_bib0071","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.3390\/cancers14112667","article-title":"Systematic review of available CAR-T Cell Trials around the World","volume":"14","author":"Barros","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trsl.2026.06.017_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104912","article-title":"Beyond CAR-T: engineered NK cell therapies (CAR-NK, NKCEs) in next-generation cancer immunotherapy","volume":"214","author":"Zhang","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114683","article-title":"Chimeric antigen receptor (CAR)-NK cell therapy in gastrointestinal (GI) cancers; a new arena","volume":"450","author":"Alkhathami","year":"2025","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.trsl.2026.06.017_bib0074","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jcyt.2025.06.006","article-title":"CAR-NK cells to treat patients with cancer: a systematic scoping review of published studies and registered clinical trials","volume":"27","author":"Rana","year":"2025","journal-title":"Cytotherapy"},{"key":"10.1016\/j.trsl.2026.06.017_bib0075","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jimmun\/vkaf012","article-title":"SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy","volume":"214","author":"Millan","year":"2025","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0076","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00262-022-03260-y","article-title":"CAR \u03b3\u03b4 T cells for cancer immunotherapy. Is the field more yellow than green?","volume":"72","author":"Ganapathy","year":"2023","journal-title":"Cancer Immunol Immun"},{"key":"10.1016\/j.trsl.2026.06.017_bib0077","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.canlet.2016.07.001","article-title":"Prospects for chimeric antigen receptor (CAR) \u03b3\u03b4 T cells: a potential game changer for adoptive T cell cancer immunotherapy","volume":"380","author":"Mirzaei","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.trsl.2026.06.017_bib0078","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.stem.2025.03.013","article-title":"Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity","volume":"32","author":"Shen","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trsl.2026.06.017_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111605","article-title":"CAR-macrophage: a new immunotherapy candidate against solid tumors","volume":"139","author":"Chen","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.trsl.2026.06.017_bib0080","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.immuni.2023.06.014","article-title":"Th1-like treg cells are dressed to suppress anti-tumor immunity","volume":"56","author":"Ramirez","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2026.06.017_bib0081","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.immuni.2017.02.016","article-title":"Exposure to bacterial CpG DNA protects from airway allergic inflammation by expanding regulatory lung interstitial macrophages","volume":"46","author":"Sabatel","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2026.06.017_bib0082","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0891-5849(98)00092-6","article-title":"Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide","volume":"25","author":"Wink","year":"1998","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.trsl.2026.06.017_bib0083","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/cimm.1999.1597","article-title":"Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells","volume":"199","author":"van der Veen","year":"2000","journal-title":"Cell Immunol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0084","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/cimm.1999.1471","article-title":"Nitric oxide inhibits the proliferation of T-helper 1 and 2 lymphocytes without reduction in cytokine secretion","volume":"193","author":"van der Veen","year":"1999","journal-title":"Cell Immunol"},{"key":"10.1016\/j.trsl.2026.06.017_bib0085","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1006\/niox.1999.0243","article-title":"Induction of nitric oxide production by natural killer cells: its role in tumor cell death","volume":"3","author":"Jyothi","year":"1999","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.trsl.2026.06.017_bib0086","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.niox.2018.12.008","article-title":"Nitric oxide synthase inhibitors 1400W and l-NIO inhibit angiogenesis pathway of colorectal cancer","volume":"83","author":"Gao","year":"2019","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.trsl.2026.06.017_bib0087","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1019195","article-title":"The nitric oxide radical scavenger carboxy-PTIO reduces the immunosuppressive activity of myeloid-derived suppressor cells and potentiates the antitumor activity of adoptive cytotoxic T lymphocyte immunotherapy","volume":"4","author":"Hirano","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.trsl.2026.06.017_bib0088","first-page":"31","article-title":"Antitumor effects of inhibitors of nitric oxide synthase or cyclooxygenase-2 on human KB carcinoma cells overexpressing COX-2","volume":"24","author":"Ohtsu","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1016\/j.trsl.2026.06.017_bib0089","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3892\/ijo.2013.2011","article-title":"Effect of a nitric oxide synthase inhibitor and a CXC chemokine receptor-4 antagonist on tumor growth and metastasis in a xenotransplanted mouse model of adenoid cystic carcinoma of the oral floor","volume":"43","author":"Takaoka","year":"2013","journal-title":"Int J Oncol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:54:34Z","timestamp":1784750074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524426001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":89,"alternative-id":["S1931524426001350"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2026.06.017","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SynNotch-iNOS CAR-macrophages remodel the tumor immune microenvironment and exhibit antitumor efficacy via a CD4+ T cell-dependent mechanism","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2026.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}